drugset
drugset / Trial / NCT00574977

Safety Study of Modified Vaccinia Virus to Cancer

NCT00574977 ↗

Phase 1 Completed 26 enrolled David Bartlett
Non-randomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to determine the safety and maximum tolerated dose from injecting this vaccinia virus into tumors or infusion.

Timeline

Start
2008-05
Primary completion
2013-01
Completion
2014-07

Drugs

EvaluationDrugModalityDoseRoute
Subject vvDD-CDSR Unknown 3e+07 unknown Other
Subject vvDD-CDSR Unknown 1e+08 unknown Other
Subject vvDD-CDSR Unknown 3e+08 unknown Other
Subject vvDD-CDSR Unknown 1e+09 unknown Other
Subject vvDD-CDSR Unknown 3e+09 unknown Other

Indications

breast cancer colorectal cancer head and neck squamous cell carcinoma liver cancer melanoma pancreatic adenocarcinoma